TheEdgeResearch
Home / Stocks / CPMD

CannaPharmaRX, Inc. (CPMD)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▼ -15.00%
Market Cap
$1.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.51
52-Wk Range
0.0003-0.01
CEO
Constantine Nkafu
Country
CA
Currency
USD

CannaPharmaRX, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Calgary, AB, CA. The stock last traded at $0.00, down 15.00% on the session, giving a market capitalisation of $1.2M. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of -654.2%. Its beta of 0.51 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.10
Price / Sales
0.70
Price / Book
-0.04
EV / EBITDA
-2.69
Gross margin
-120.4%
Operating margin
-202.7%
Net margin
-654.2%
Return on equity
Debt / equity
-0.69
Current ratio
0.03
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
26
IPO date
1999-10-29
Headquarters
Calgary, AB, CA
About CannaPharmaRX, Inc.

CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector. The company focuses on identifying, acquiring, and developing diverse projects for cultivating cannabis. Founded in 1998, its main offices are located in Calgary, Canada.

Comparable companies

CannaPharmaRX, Inc. is most often compared with the following Healthcare names:

ALIDAPPBCBDYCNNAEXMTLVVEFMJARFMSTHPLSHSRUTF
More research on CPMD
CPMD technical analysis CPMD TheEdge Score Compare against peers
Open full interactive analysis & DCF →